(UPDATED) Muddy conclusions from the GUIDE-HF trial hint that pulmonary artery pressure monitoring with the CardioMEMS device (Abbott) may help prevent heart failure (HF) hospitalizations in a broader ...

Endotronix presented positive six-month results from its PROACTIVE-HF pivotal trial of the investigational Cordella Pulmonary Artery (PA) Sensor on March 5. The trial, in New York Heart Association ...

(UPDATED) An adhesive, wearable sensor the size and shape of a small sanitary napkin, in combination with machine learning, may give implantable devices a run for their money in forecasting heart ...

Please provide your email address to receive an email when new articles are posted on . Abbott announced its sensor providing hemodynamic-guided management of patients with HF has received an expanded ...

Please provide your email address to receive an email when new articles are posted on . The FDA granted premarket approval to Endotronix’s pulmonary artery sensor platform for remote management of ...

Heart failure is the top hospital discharge diagnosis in the U.S. and affects more than 23 million people worldwide. While heart failure itself isn't always deadly, its level of rehospitalization is ...

Heart failure, which affects nearly 6 million Americans, is a condition in which the heart cannot pump enough blood at the right pressures to meet the body's needs. CardioMEMS is a small sensor—the ...

For most patients suffering from heart failure today, care is episodic. Medication and other treatments are only adjusted when a patient is hospitalized or sees their doctor during periodic office ...

At Mount Sinai hospital in New York, cardiologists have started using microchip sensors in patients with advanced heart failure to monitor their symptoms and help reduce their chances of return visits ...

There is a critical need for non-invasive solutions to monitor heart failure progression around the clock. This novel wearable device is based on sensors embedded in a lightweight belt that monitors ...

TEL AVIV, Israel--(BUSINESS WIRE)--Vectorious Medical Technologies Ltd., an innovator in implantable hemodynamic monitoring in heart failure (HF), today announced results of VECTOR-HF I, a ...

TEL AVIV, Israel--(BUSINESS WIRE)--Vectorious Medical Technologies Ltd., today announced that it has enrolled the first six patients in the VECTOR-HF II Study, which will evaluate the V-LAP System’s ...